HK1146914A1 - Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder - Google Patents

Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder

Info

Publication number
HK1146914A1
HK1146914A1 HK11100935.5A HK11100935A HK1146914A1 HK 1146914 A1 HK1146914 A1 HK 1146914A1 HK 11100935 A HK11100935 A HK 11100935A HK 1146914 A1 HK1146914 A1 HK 1146914A1
Authority
HK
Hong Kong
Prior art keywords
acidophilus
treatment
pharmaceutical compositions
bifidobacterium lactis
functional bowel
Prior art date
Application number
HK11100935.5A
Other languages
English (en)
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40549819&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1146914(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Publication of HK1146914A1 publication Critical patent/HK1146914A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK11100935.5A 2007-10-11 2011-01-28 Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder HK1146914A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97918707P 2007-10-11 2007-10-11
PCT/US2008/079177 WO2009048934A2 (en) 2007-10-11 2008-10-08 Probiotics for use in relieving symptoms associated with gastrointestinal disorders

Publications (1)

Publication Number Publication Date
HK1146914A1 true HK1146914A1 (en) 2011-07-22

Family

ID=40549819

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11100935.5A HK1146914A1 (en) 2007-10-11 2011-01-28 Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder

Country Status (11)

Country Link
US (1) US9055763B2 (ja)
EP (1) EP2209527B1 (ja)
JP (2) JP5758629B2 (ja)
CN (1) CN101998834B (ja)
AU (2) AU2008310961B2 (ja)
CA (1) CA2702293C (ja)
DK (1) DK2209527T3 (ja)
ES (1) ES2399775T3 (ja)
HK (1) HK1146914A1 (ja)
PL (1) PL2209527T3 (ja)
WO (1) WO2009048934A2 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
SG11201604840TA (en) * 2014-02-28 2016-09-29 Meiji Co Ltd Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
EP3524051A1 (en) 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions
CA3092548A1 (en) * 2018-03-05 2019-09-12 Bio-K Plus International Inc. Combination of lactobacilli for the relief of irritable bowel syndrome and for the relief of other gastrointestinal disorders
EP3821718A1 (en) * 2019-11-15 2021-05-19 DuPont Nutrition Biosciences ApS Probiotics for lactose intolerance
US11742069B2 (en) * 2021-02-01 2023-08-29 Kpn Innovations, Llc. Systems and methods for generating a nociception nourishment program
WO2023154787A1 (en) * 2022-02-09 2023-08-17 The Regents Of The University Of Michigan Compositions and methods for modulating gut microbiomes
CN116746683A (zh) * 2023-08-01 2023-09-15 河北源民生物科技有限公司 防消化不良胀气、促吸收的动物双歧杆菌乳亚种bal-28及发酵产物、菌群cw和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4196132B2 (ja) * 1997-12-22 2008-12-17 小林製薬株式会社 脱ガス組成物
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7179460B2 (en) * 2002-12-05 2007-02-20 Danisco A/S Bacterial composition and its use
US20070148147A1 (en) * 2002-12-05 2007-06-28 Veronique Dennin Bacterial composition and its use
FR2875406B1 (fr) 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
BRPI0707336A2 (pt) * 2006-01-27 2011-05-03 Danisco uso de microorganismos probióticos para o tratamento e prevenção de obesidade e distúrbios relacionados

Also Published As

Publication number Publication date
AU2014210581B2 (en) 2016-07-14
WO2009048934A2 (en) 2009-04-16
ES2399775T3 (es) 2013-04-03
WO2009048934A3 (en) 2009-10-29
US9055763B2 (en) 2015-06-16
AU2008310961A1 (en) 2009-04-16
JP5758629B2 (ja) 2015-08-05
AU2014210581A1 (en) 2014-08-28
CN101998834B (zh) 2017-05-10
CN101998834A (zh) 2011-03-30
CA2702293A1 (en) 2009-04-16
US20110033423A1 (en) 2011-02-10
DK2209527T3 (da) 2013-03-18
PL2209527T3 (pl) 2013-03-29
CA2702293C (en) 2016-08-02
JP2011501664A (ja) 2011-01-13
EP2209527B1 (en) 2012-12-05
EP2209527A2 (en) 2010-07-28
AU2008310961B2 (en) 2014-08-28
JP5674741B2 (ja) 2015-02-25
JP2013040186A (ja) 2013-02-28

Similar Documents

Publication Publication Date Title
HK1146914A1 (en) Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder
PL1773361T3 (pl) Kompozycje oparte na bakteriach probiotycznych i ich zastosowanie w profilaktyce i/lub leczeniu patologii i/lub zakażeń układu oddechowego oraz poprawie funkcji jelit
PL2219658T3 (pl) Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
ZA200905886B (en) Methods and kits for administering probiotics
EP2046352A4 (en) FERMENTED MILK PRODUCT AND ITS USE
IL199045A0 (en) Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
EP2007385A4 (en) CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
PL2435056T3 (pl) Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
EP2087094A4 (en) LACTOBACILLUS FERMENTUM ESS-1, DSM17851 AND ITS USE IN THE TREATMENT AND / OR PREVENTION OF CANDIDOSIS AND URINARY TRACT INFECTIONS
IL216599A (en) 4,1-Bi-Conjugated Phthalazine History, Pharmaceuticals Containing Them and Their Use in Cancer Treatment
PL2308566T3 (pl) Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna
HK1152968A1 (en) New probiotic bifidobacterium longum
EP2064550A4 (en) PRRG4 ASSOCIATED COMPOSITIONS AND METHOD FOR USE THEREOF FOR TUMOR DIAGNOSTIC PROCEDURES
AP2957A (en) New antibodies specific of the Beta-amyloid peptides and their uses as diagnostic agents or drugs
EP2010645A4 (en) RECOMBINANT LACTOBACILLUS AND USE THEREOF
GB0720983D0 (en) Catalyst particles their preparation and use
IL204990A0 (en) Use of 3,11 b-cis - dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
GB0722996D0 (en) Depsipeptides and their therapeutic use
PL2068899T3 (pl) Lactobacillus acidophilus do zastosowania w zmniejszaniu częstości występowania i czasu trwania zakażeń dróg oddechowych
HK1198326A1 (zh) 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
GB2452696B (en) 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
GB0908868D0 (en) Depsipeptide and their therapeutic use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161008